Sten Verland
Co-Founder & General Partner @ Sunstone Life Science Ventures
Copenhagen, Denmark
Sten Verland is a partner in the Life Science group and one of the three co-founders. Sten focuses on therapeutics investments.During his career, Sten has been active as a serial entrepreneur and business angel and has co-founded ten start-ups, primarily in the biotech and CRO fields. While at Sunstone, Sten has played a key role in executingtwo exits (Action Pharma and Zymenex). Both deals made it to the global Top Ten list of published upfront cash deals in 2007-2012. Sten holds a Master’s degree in Biology and Mathematics and a PhD in Immunology – both from the University of Copenhagen. Sten serves as a board member of the Danish Venture Capital Association. In his spare time, Sten is both a keen yachtsman and a big admirer of classical music.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sten Verland invests in
Stages Sten Verland invests in
Countries Sten Verland invests in
Investment Focus
Industry
- Therapeutics 2 (100%)
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Health Care 1 (50%)
- Developer Platform 1 (50%)
Stage
- Series A 1 (50%)
- Funding Round 1 (50%)
Country
- Germany 1 (50%)
- Switzerland 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rigontec
|
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options. | $5.3M / Series A / Mar 24, 2015 | |
Vaximm
|
Vaximm is focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Their initial product candidate VXM01 is targeting the tumor vasculature, which is essential for tumors to grow beyond microscopic size. Vaximm has shown impressive anti-tumor activity in various animal studies and will enter first human clinicaltrials in 2011. | $8.5M / Jan 12, 2011 |
Co-Investors
About Sunstone Life Science Ventures
Sunstone Life Science Ventures is a European, early-stage VC investing in novel pharmaceutical ingredients for human therapeutic use
Sunstone Life Science Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Claus A. Andersson
General Partner
|
|||
Jacob Lange Moresco
Investment Director
|
|||
Line Jacobsen
Management Assistant
|
|||
Peter Benson
Chairman and Managing Partner
|
|||
|
Sten Verland
Co-Founder & General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sten Verland invest in?
Sten Verland invests primarily in Therapeutics, Biotechnology and Medical startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sten Verland last invest?
The most recent investment recorded for Sten Verland closed in Mar 2015. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
